Freedom Day Solutions, LLC Vertex Pharmaceuticals Inc Transaction History

Freedom Day Solutions, LLC

$319 Million
Q3 2024

A detailed history of Freedom Day Solutions, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Freedom Day Solutions, LLC holds 5,909 shares of VRTX stock, worth $2.35 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

5,909

Previous 5,891 0.31%

Holding current value

$2.35 Million

Previous $2.76 Million 0.47%

% of portfolio

0.86%

Previous 0.94%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$460.0 - $505.78 $8,280 - $9,104	18 Added 0.31%	5,909 $2.75 Million
Q2 2024 Jul 19, 2024	BUY	$392.81 - $485.53 $93,095 - $115,070	237 Added 4.19%	5,891 $2.76 Million
Q1 2024 Apr 24, 2024	SELL	$407.69 - $446.08 $22,015 - $24,088	-54 Reduced 0.95%	5,654 $2.36 Million
Q4 2023 Jan 29, 2024	BUY	$343.0 - $410.68 $338,198 - $404,930	986 Added 20.88%	5,708 $2.32 Million
Q3 2023 Oct 25, 2023	BUY	$338.18 - $362.46 $38,890 - $41,682	115 Added 2.5%	4,722 $1.64 Million
Q2 2023 Jul 24, 2023	BUY	$314.42 - $351.91 $55,337 - $61,936	176 Added 3.97%	4,607 $1.62 Million
Q1 2023 Apr 24, 2023	BUY	$283.23 - $323.1 $178,151 - $203,229	629 Added 16.54%	4,431 $1.4 Million
Q4 2022 Feb 07, 2023	BUY	$285.76 - $321.48 $1.09 Million - $1.22 Million	3,802 New	3,802 $1.1 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $320,045 - $377,417	-1,707 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$207.02 - $241.31 $53,411 - $62,257	258 Added 17.81%	1,707 $367,000
Q4 2020 Jan 28, 2021	SELL	$207.01 - $276.09 $596,188 - $795,139	-2,880 Reduced 66.53%	1,449 $342,000
Q3 2020 Oct 26, 2020	SELL	$255.65 - $303.1 $26,331 - $31,219	-103 Reduced 2.32%	4,329 $1.17 Million
Q2 2020 Jul 27, 2020	BUY	$225.48 - $295.8 $999,327 - $1.31 Million	4,432 New	4,432 $1.29 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedom Day Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freedom Day Solutions, LLC with notifications on news.

Account

Freedom Day Solutions, LLC Vertex Pharmaceuticals Inc Transaction History